论文部分内容阅读
目的:分析米非司酮治疗更年期功能性子宫出血的临床效果。方法:选取我院2013年1月-2013年12月接收的102例更年期功能性子宫出血患者作为研究对象,将其随机分为实验组与对照组,对照组患者采用甲羟孕酮治疗,而实验组患者采用米非司酮治疗,然后对两组患者的治疗效果予以对比。结果:实验组患者的治疗有效率明显好于对照组,经相关药物治疗之后,实验组患者的FSH、LH、E2、P等性激素指标均要低于对照组,并且两组之间的差异具有统计学意义(PO.05)。结论:对更年期功能性子宫出血患者采取有效的药物进行治疗,可以提高患者的临床治疗效果,还有助于降低不良反应的发生率。
Objective: To analyze the clinical effect of mifepristone in treating menopausal functional uterine bleeding. Methods: A total of 102 cases of climacteric functional uterine bleeding from January 2013 to December 2013 in our hospital were selected as study subjects. They were randomly divided into experimental group and control group, while those in control group were treated with medroxyprogesterone acetate Patients in the experimental group were treated with mifepristone, and then the treatment effect was compared between the two groups. Results: The effective rate of treatment in experimental group was significantly better than that in control group. After treatment with relevant drugs, the indexes of FSH, LH, E2, P and other hormones in experimental group were lower than those in control group, and the difference between the two groups was Statistical significance (P <0.05), two groups of patients with no significant difference in the incidence of adverse reactions, not statistically significant (P> 0.05). Conclusion: Taking effective drugs for climacteric patients with functional uterine bleeding can improve the clinical curative effect of patients and reduce the incidence of adverse reactions.